NCT03418038 2026-03-18Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaMayo ClinicPhase 2 Recruiting80 enrolled
NCT05180097 2026-02-02Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin LymphomaCanadian Cancer Trials GroupPhase 2 Recruiting84 enrolled